BioSpace News Archive

Meridian Bioscience, Inc. will report third quarter fiscal 2021 financial results Friday, August 6, 2021.

Auris Medical Holding Ltd. today nnounced additional preclinical data in a model of primary human nasal airway epithelium from its Bentrio™ (AM-301) nasal spray development program in SARS-CoV-2. AM-301 was found to be safe in vitro, and it significantly decelerated viral titer growth in experimental models of prophylaxis and mitigation.

Through the continued threat of COVID-19, the need for reliable methods to detect and trace viral variants is constantly increasing.

PsyBio Therapeutics Corp. is pleased to announce that its subordinate voting shares will commence trading on the OTCQB Venture Market at the market open on July 14, 2021 under the symbol “PSYBF”.

ScienceMedia announces that SMi Trial’s fully mobile, fully compatible, just-in-time solution closes the loop in clinical trials. Clinical trials are embedded in a clinical process of humans caring for humans.

Cognito Therapeutics today announced the acceptance of six research abstracts at the Alzheimer’s Association International Conference ® 2021 (AAIC ® ) .

Iterion Therapeutics, Inc., a venture-backed, clinical-stage biotechnology company developing novel cancer therapeutics, today announced the appointment of Jean Chang to the position of Chief Operating Officer.

Kriya Therapeutics, Inc. today announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.

Schrödinger today announced that management will present at two investor conferences in July. On Tuesday, July 20, 2021, Schrödinger will provide a corporate overview at the Evercore ISI AI x Therapeutics Day. The presentation will take place virtually at 1:30 pm. ET.

Essenlix Corporation today announced that Dieter Weinand has joined the company as Executive Chairman of its Board of Directors.